🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Kōichi Goto

National Cancer Center Hospital East

ORCID: 0000-0002-3023-2510
MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 5%percentile
0.452Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

35P Final data from phase I/II LIBRETTO-001 trial of selpercatinib in RET fusion-positive non-small cell lung cancer

ESMO Open(2024)10.1016/j.esmoop.2024.102614
Top 42%
0.452DataRank
Top 42%8 citations

Alexander Drilon, Benjamin Solomon, Pascale Tomasini, Herbert H. Loong, Filippo de Braud +7 more

Papers

Driven by 10 papers — median percentile 58. Top paper: “First-Line Selpercatinib or Chemotherapy and Pembrolizumab in RET Fusion–Positive NSCLC”.

First-Line Selpercatinib or Chemotherapy and Pembrolizumab in RET Fusion–Positive NSCLC

New England Journal of Medicine(2023)10.1056/nejmoa2309457
N/A
4.6DataRank · unranked
218 citations

Benjamin Solomon, Herbert H. Loong, Keunchil Park, M. Pérol, Edurne Arriola +19 more

Genome-wide association study of lung adenocarcinoma in East Asia and comparison with a European population

Nature Communications(2023)10.1038/s41467-023-38196-z
N/A
0.646DataRank · unranked
73 citations

Kouya Shiraishi, Jiyeon Choi, Keitaro Matsuo, Tzu-Yu Chen, Juncheng Dai +95 more

35P Final data from phase I/II LIBRETTO-001 trial of selpercatinib in RET fusion-positive non-small cell lung cancer

ESMO Open(2024)10.1016/j.esmoop.2024.102614
Top 42%
0.452DataRank
Top 42%8 citations

Alexander Drilon, Benjamin Solomon, Pascale Tomasini, Herbert H. Loong, Filippo de Braud +7 more

Data from Single-Cell Analyses Reveal Diverse Mechanisms of Resistance to EGFR Tyrosine Kinase Inhibitors in Lung Cancer

(2023)10.1158/0008-5472.c.6512902.v1
N/A
0DataRank · unranked
0 citations

Daisuke Shibahara, Ayako Suzuki, Kyoko Muto, Ikei S. Kobayashi, David Plotnick +12 more

Stratifying Lung Adenocarcinoma Risk with Multi-ancestry Polygenic Risk Scores in East Asian Never-Smokers

medRxiv(2024)10.1101/2024.06.26.24309127
N/A
0DataRank · unranked
0 citations

Xiaoyu Wang, Juncheng Dai, Christiana Karsonaki, Jianxin Shi, Kouya Shiraishi +95 more

Efficacy of EGFR tyrosine kinase inhibitors in patients with non–small cell lung cancer with EGFR exon 19 insertions: clinical-genomic, preclinical analysis through LC-SCRUM-Asia (multi-institutional genomic screening registry)

Lung Cancer(2025)10.1016/j.lungcan.2025.108479
N/A
0DataRank · unranked
0 citations

Hiroki Izumi, Ikei S. Kobayashi, Shingo Matsumoto, Yukio Hosomi, Takae Okuno +23 more

540P Entrectinib in patients with ROS1 fusion-positive non-small cell lung cancer (NSCLC) or NTRK fusion-positive solid tumours: Analysis of response by line of therapy

Annals of Oncology(2020)10.1016/j.annonc.2020.08.654
N/A
0DataRank · unranked
1 citations

Filippo de Braud, Alexander Drilon, Robert C. Doebele, Manish R. Patel, Byoung Chul Cho +15 more

Stratifying lung adenocarcinoma risk with multi-ancestry polygenic risk scores in East Asian never-smokers

JNCI Journal of the National Cancer Institute(2025)10.1093/jnci/djaf272
N/A
0DataRank · unranked
0 citations

Xiaoyu Wang, Juncheng Dai, Christiana Karsonaki, Jianxin Shi, Kouya Shiraishi +95 more

Single-Cell Analyses Reveal Diverse Mechanisms of Resistance to EGFR Tyrosine Kinase Inhibitors in Lung Cancer

Cancer Research(2021)10.1158/0008-5472.can-20-2811
N/A
0DataRank · unranked
104 citations

Daisuke Shibahara, Ayako Suzuki, Kyoko Muto, Ikei S. Kobayashi, David Plotnick +12 more

Hypersensitivity Reactions to Selpercatinib Treatment With or Without Prior Immune Checkpoint Inhibitor Therapy in Patients With NSCLC in LIBRETTO-001

Journal of Thoracic Oncology(2022)10.1016/j.jtho.2022.02.004
N/A
0DataRank · unranked
57 citations

Christian Rolfo, Alexander Drilon, Mario E. Lacouture, Benjamin Besse, Kōichi Goto +10 more